Co-Diagnostics/$CODX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Co-Diagnostics
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Ticker
$CODX
Sector
Primary listing
Employees
115
Headquarters
Website
Co-Diagnostics Metrics
BasicAdvanced
$27m
-
-$29.82
-
-
Price and volume
Market cap
$27m
52-week high
$11.85
52-week low
$1.26
Average daily volume
10m
Financial strength
Current ratio
2.283
Quick ratio
1.94
Long term debt to equity
7.31
Total debt to equity
12.656
Profitability
EBITDA (TTM)
-30.837
Gross margin (TTM)
45.06%
Net profit margin (TTM)
-6,753.69%
Operating margin (TTM)
-4,447.20%
Effective tax rate (TTM)
3.25%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-52.09%
Return on equity (TTM)
-151.66%
Valuation
Price to revenue (TTM)
16.533
Price to book
1.64
Price to tangible book (TTM)
2.98
Growth
Revenue change (TTM)
-79.47%
Earnings per share change (TTM)
-14.84%
3-year revenue growth (CAGR)
-61.02%
3-year earnings per share growth (CAGR)
-1.79%
Co-Diagnostics News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs